158 related articles for article (PubMed ID: 34138687)
21. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
22. Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Moon KC
Hum Pathol; 2013 Oct; 44(10):2047-54. PubMed ID: 23668999
[TBL] [Abstract][Full Text] [Related]
23. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
Hu S; Meng F; Yin X; Cao C; Zhang G
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
[TBL] [Abstract][Full Text] [Related]
24. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
25. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
Gao XY; Li L; Wang XH; Wen XZ; Ji K; Ye L; Cai J; Jiang WG; Ji JF
Oncol Rep; 2015 Oct; 34(4):1977-87. PubMed ID: 26239167
[TBL] [Abstract][Full Text] [Related]
27. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.
Wang J; Liu L; Sun Y; Xue Y; Qu J; Pan S; Li H; Qu H; Wang J; Zhang J
Biomed Pharmacother; 2018 May; 101():406-413. PubMed ID: 29501762
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of FNDC1 Relates to Poor Prognosis and Its Knockdown Impairs Cell Invasion and Migration in Gastric Cancer.
Liu YP; Chen WD; Li WN; Zhang M
Technol Cancer Res Treat; 2019 Jan; 18():1533033819869928. PubMed ID: 31530096
[TBL] [Abstract][Full Text] [Related]
29. The effect and clinical significance of FN1 expression on biological functions of gastric cancer cells.
Zhou Y; Cao G; Cai H; Huang H; Zhu X
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):191-198. PubMed ID: 33040835
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.
Li H; Wang Y
Med Sci Monit; 2019 Jan; 25():656-665. PubMed ID: 30670679
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic significance of Livin in gastric cancer.
Chung CY; Park YL; Kim N; Park HC; Park HB; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
Oncol Rep; 2013 Nov; 30(5):2520-8. PubMed ID: 24008725
[TBL] [Abstract][Full Text] [Related]
34. NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.
Zhang Z; She J; Yang J; Bu X; Ji G; Zhu S; He S; Chu D
Mol Carcinog; 2018 Jun; 57(6):762-771. PubMed ID: 29500881
[TBL] [Abstract][Full Text] [Related]
35. CSTB Downregulation Promotes Cell Proliferation and Migration and Suppresses Apoptosis in Gastric Cancer SGC-7901 Cell Line.
Zhang J; Shi Z; Huang J; Zou X
Oncol Res; 2016 Oct; 24(6):487-494. PubMed ID: 28281969
[TBL] [Abstract][Full Text] [Related]
36. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
37. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.
Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y
PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
Zhou YZ; Li CZ; Gao H; Zhang YZ
World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of cell growth by activin in SNU-16 cells.
Kim YI; Lee HJ; Khang I; Cho BN; Lee HK
World J Gastroenterol; 2006 May; 12(19):3000-5. PubMed ID: 16718778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
